Key facts
- Angle Health raised $200 million in a Series C funding round.
- The company's valuation reached $2.7 billion.
- A $400 million tender offer was also announced.
- Vitruvian Partners led the round, with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator.
- Angle Health helps small businesses obtain and manage level-funded health plans.
- The company serves over 5,000 businesses and is profitable.
Health insurance startup Angle Health announced on Friday, September 18, 2026, that it raised $200 million in a Series C funding round, achieving a valuation of $2.7 billion. The company also secured a $400 million tender offer, which allows employees to cash out some of their shares. The round was led by Vitruvian Partners, with participation from Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. The tender offer is expected to close later this month.
Angle Health, a winter 2020 YC alum, focuses on providing level-funded health plans to small businesses. These plans are positioned between fully insured and self-funded options, offering predictable payments to carriers while insuring against higher-than-expected costs and potentially returning surplus funds if expenses remain low. The company claims these plans make health insurance more affordable for small businesses. Its AI-powered platform integrates with payroll and HR systems to help businesses select and manage plans. Angle Health reports serving over 5,000 businesses and achieving profitability.
